National Research Co. (NASDAQ:NRCIA) has been assigned an average broker rating score of 3.00 (Hold) from the one brokers that provide coverage for the company, Zacks Investment Research reports. One investment analyst has rated the stock with a hold rating.
Zacks has also assigned National Research an industry rank of 50 out of 265 based on the ratings given to related companies.
A number of equities research analysts have recently commented on NRCIA shares. Zacks Investment Research raised National Research from a “strong sell” rating to a “hold” rating in a research note on Wednesday, January 10th. BidaskClub raised National Research from a “hold” rating to a “buy” rating in a research note on Wednesday, December 27th.
In other news, major shareholder Amandla Mk Trust bought 5,494,440 shares of the stock in a transaction on Thursday, February 15th. The shares were bought at an average price of $19.31 per share, with a total value of $106,097,636.40. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Michael D. Hays sold 1,602,399 shares of the stock in a transaction dated Thursday, January 25th. The shares were sold at an average price of $39.03, for a total value of $62,541,632.97. Following the completion of the transaction, the chief executive officer now directly owns 5,261,410 shares in the company, valued at approximately $205,352,832.30. The disclosure for this sale can be found here. Company insiders own 37.54% of the company’s stock.
A number of hedge funds have recently bought and sold shares of NRCIA. Northern Trust Corp raised its stake in shares of National Research by 11.5% in the second quarter. Northern Trust Corp now owns 144,413 shares of the business services provider’s stock worth $3,884,000 after buying an additional 14,856 shares during the period. Vanguard Group Inc. raised its stake in shares of National Research by 2.8% in the second quarter. Vanguard Group Inc. now owns 260,010 shares of the business services provider’s stock worth $6,994,000 after buying an additional 7,177 shares during the period. State Street Corp raised its stake in shares of National Research by 12.2% in the second quarter. State Street Corp now owns 157,748 shares of the business services provider’s stock worth $4,241,000 after buying an additional 17,163 shares during the period. The Manufacturers Life Insurance Company raised its stake in shares of National Research by 252.1% in the second quarter. The Manufacturers Life Insurance Company now owns 9,090 shares of the business services provider’s stock worth $244,000 after buying an additional 6,508 shares during the period. Finally, Macquarie Group Ltd. bought a new position in shares of National Research in the third quarter worth about $488,000. 33.66% of the stock is currently owned by institutional investors.
Shares of National Research (NASDAQ NRCIA) traded down $0.10 during mid-day trading on Friday, reaching $31.50. The company had a trading volume of 30,313 shares, compared to its average volume of 22,423. The stock has a market capitalization of $773.28, a PE ratio of 60.58 and a beta of 1.75. National Research has a 12 month low of $18.10 and a 12 month high of $41.99.
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, April 13th. Investors of record on Friday, March 30th will be given a dividend of $0.10 per share. The ex-dividend date is Wednesday, March 28th. This represents a $0.40 annualized dividend and a dividend yield of 1.27%. National Research’s dividend payout ratio (DPR) is presently 76.92%.
COPYRIGHT VIOLATION WARNING: This report was originally published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this report on another site, it was illegally copied and republished in violation of international copyright and trademark legislation. The correct version of this report can be read at https://www.dispatchtribunal.com/2018/04/08/zacks-national-research-co-nrcia-receives-average-rating-of-hold-from-brokerages.html.
National Research Company Profile
National Research Corporation, doing business as NRC Health, is a provider of analytics and insights for healthcare providers, payers and other healthcare organizations. The Company operates through six segments: Experience, The Governance Institute, Market Insights, Transparency, National Research Corporation Canada and Connect.
Get a free copy of the Zacks research report on National Research (NRCIA)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for National Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Research and related companies with MarketBeat.com's FREE daily email newsletter.